An Eleven Year Follow-up of Delayed-type Hypersensitivity Testing for the Identification of HIV-1 Infected Patients at Increased Risk of Developing AIDS

References

• Platt J L, Grant B W, Eddy A A, Michael A F. Immune cell populations in cutaneous delayed-typed hypersensitivity. J Exp Med 1983; 158: 1227–1242
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C H. Delayed hypersensitivity. Immunologic diseases, 4th edn., M Samter. Little, Brown & Co., Boston 1988; 270–273
   Google Scholar
• Waldmann T A. Immunodeficiency diseases: primary and acquired. Immunological disease, 4th edn., M Samter. Little, Brown & Co., Boston 1988; 411–465
   Google Scholar
• Polis M A, Masur H. Predicting the progression to AIDS. Am J Med 1990; 89: 701–705
   PubMedGoogle Scholar
• Schnittman S M, Psallidopoulos M C, Lane H C, Thompson L, Baseler M, Massari F, Fox C H, Salzman N P, Fauci A S. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989; 245: 305–308
   PubMed Web of Science ®Google Scholar
• Michael N L, Vahey M, Burke D S, Redfield R R. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 1992; 66: 310–316
   PubMed Web of Science ®Google Scholar
• Fauci A S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988; 239: 617–622
   PubMed Web of Science ®Google Scholar
• Teeuwsen V JP, Siebelink K HJ, de Wolf F, Goudsmit J, Uytde Haag F GCM, Osterhaus A DME. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. AIDS 1990; 4: 77–81
   PubMedGoogle Scholar
• Bratt G, von Krogh G, Moberg L, Karlsson A, Putkonen P O, Biberfeld G, Böttiger M, Sandström E. Intradermal testing with multiple recall antigens for identification of cell-mediated immune deficiency in homosexual men. Clin Immunol Immunopathol 1986; 41: 206–215
   PubMedGoogle Scholar
• Birx D L, Brundage J, Larson K, Engler R, Smith L, Squire E, Carpenter G, Sullivan M, Rhoads J, Oster C, James W, Lupton G, Wierzba T, Burke D, Redfield R, Research TMMCfAR. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. J Acquir Immune Defic Syndr 1993; 6: 1248–1257
   PubMedGoogle Scholar
• Karlsson A, Bratt G, von Krogh G, Morfeldt-Månson L, Böttiger B, Sandström E. A prospective study of 115 initially asymptomatic HIV infected gay men in Stockholm, Sweden. Scand J Infect Dis 1991; 23: 431–441
   PubMed Web of Science ®Google Scholar
• Kniker W T, Anderson C T, McBryde J L, Roumiantzeff M, Lesourd B. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the USA. Ann Allergy 1984; 52: 75–82
   PubMedGoogle Scholar
• CDC. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986; 35: 334–339
   PubMedGoogle Scholar
• CDC. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36(Suppl. 1)S1–S15
   PubMedGoogle Scholar
• von Krogh G, Broström C, Hermanson J, von Sydow M, Biberfeld G, Sandström E, Böttiger M. The introduction of HIV during 1979–80 in a sexually active homosexual population of Stockholm. Scand J Infect Dis 1987; 19: 285–288
   PubMedGoogle Scholar
• Cooper G S, Jeffers D J. The clinical prognosis of HIV-1 infection: a review of 32 follow-up studies. J Gen Intern Med 1988; 3: 525–532
   PubMed Web of Science ®Google Scholar
• Moss A R, Bacchetti P. Natural history of HIV infection. AIDS 1989; 3: 55–61
   PubMed Web of Science ®Google Scholar
• Kaplan J E, Spira T J, Fishbein D B, Lynn H S. Ten-year followup of HIV-infected homosexual men with lymphadenopathy syndrome: evidence for continuing risk of developing AIDS. J Acquir Immune Defic Syndr 1992; 5: 565–570
   PubMedGoogle Scholar
• Buchbinder S P, Katz M, Hessol N, O'Malley P, Barnhart J, Holmberg S. Healthy long-term positives: men infected with HIV for more than 10 years with CD4 counts greater than 500 cells. Int Conf AIDS (Netherlands) 1992; 8, abstr. TuC 0572
   Google Scholar
• Buchbinder S, Elbeik T, Harrer T, Feinberg M B, Walker B D, O'Malley P M, Scheer S, Holmberg S, Katz M H. Healthy long-term HIV positives: viral burden and cell-mediated immunity. Int Conf AIDS (Japan) 1994; 10, abstr. 007C
   Google Scholar
• Pedersen C, Gerstoft J, Tauris P, Lundgren J D, Gøtzsche P C, Buhl M, Salim Y, Schmidt K. Opportunistic infections and malignancies in 231 Danish AIDS patients. AIDS 1990; 4: 233–238
   PubMed Web of Science ®Google Scholar
• Phair J P, Kauffman C A, Bjornson A. Investigation of host defense mechanisms in the aged as determinants of nosocomial colonization and pneumonia. J Reticulend Soc 1978; 23: 397
   PubMedGoogle Scholar
• Sohnle P G, Larson S E, Collins-Lech C, Guansing A R. Failure of lympholine-producing lymphocytes from aged humans to undergo activation by recall antigens. J Immunol 1980; 124: 2169
   PubMedGoogle Scholar
• Teasdale C, Hughes L E, Whithead R H, Newcombe R G. Factors affecting pretreatment immune competence in cancer patients. I. The effects of age, sex, and ill health. II. The corrected effects of malignant disease. Cancer Immunol Immunother 1979; 6: 88
   Google Scholar
• Roberts-Thomson I C, Whittingham S, Younchaiyud U, Mackay I R. Aging, immune response, and mortality. Lancet 1974; 7877: 368
   Google Scholar
• Waldorf D S, Willkens R F, Decker J L. Impaired delayed hypersensitivity in an aging population. JAMA 1968; 203: 831
   PubMedGoogle Scholar
• Grossman J, Baum J, Gluckman J, Fusner J, Condemi J J. The effect of aging and acute illness on delayed hypersensitivity. J Allerg 1975; 55: 268
   Google Scholar
• Palmer D L, Reed W P. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis 1974; 130: 132
   PubMed Web of Science ®Google Scholar
• Schnittman S M, Greenhouse J J, Psallidopoulos M C, Baseler M, Salzman N P, Fauci A S, Lane H C. Increasing viral burden in CD4 + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990; 113: 438–443
   PubMed Web of Science ®Google Scholar
• Saag M S, Crain M J, Decker W, Campbell-Hill S, Robinson S, Brown W E, Leuther M, Whitley R J, Hahn B H, Shaw G M. High-level viremia in adult and children infected with human immunodeficiency virus: relation to disease stage and CD4 + lymphocyte levels. J Infect Dis 1991; 164: 72–80
   PubMedGoogle Scholar
• Clerici M, Shearer G M. TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107–111
   PubMedGoogle Scholar